SEGMENT INFORMATION - Summary of Reportable Segments (Details) $ in Thousands		12 Months Ended
	Jan. 01, 2023 segment	Dec. 31, 2022 USD ($) segment	Dec. 31, 2021 USD ($) segment	Dec. 31, 2020 USD ($) segment
Segment Reporting [Abstract]
Number of reportable segments | segment		3	3	3
Financial information regarding the Company's reportable segments
Net Sales		$ 3,322,249	$ 3,227,221	$ 2,929,340
Acquisition-related costs		(231)	(3,811)	(6,087)
Restructuring initiatives		(6,597)	(23,240)	(26,492)
Net unrealized investment gain		(3,323)	2,709	0
Depreciation and amortization		(233,706)	(234,853)	(220,300)
Interest expense		(40,827)	(30,284)	(33,244)
Interest income		2,700	3,668	958
Income before Income Taxes		334,704	321,655	301,155
Capital Expenditures:		310,427	307,935	245,954
Total Assets		$ 4,203,458	$ 4,141,364	$ 3,990,053
Number of reportable segments | segment		3	3	3
Subsequent Events
Segment Reporting [Abstract]
Number of reportable segments | segment	3
Financial information regarding the Company's reportable segments
Number of realigned segments | segment	2
Number of reportable segments | segment	3
Pharma
Financial information regarding the Company's reportable segments
Net Sales		$ 1,361,256	$ 1,284,624	$ 1,225,779
Restructuring initiatives		0	(76)	(220)
Beauty + Home
Financial information regarding the Company's reportable segments
Net Sales		1,438,534	1,434,022	1,298,151
Restructuring initiatives		(6,460)	(10,447)	(24,464)
Food + Beverage
Financial information regarding the Company's reportable segments
Net Sales		522,459	508,575	405,410
Restructuring initiatives		(137)	(404)	(1,903)
Operating Segments
Financial information regarding the Company's reportable segments
Net Sales		3,357,986	3,265,316	2,962,530
Operating Segments | Pharma
Financial information regarding the Company's reportable segments
Net Sales		1,372,449	1,297,996	1,234,107
Adjusted EBITDA		441,622	425,714	428,469
Depreciation and amortization		(94,396)	(90,510)	(75,874)
Capital Expenditures:		164,396	154,077	117,835
Total Assets		1,872,843	1,833,512	1,549,781
Operating Segments | Beauty + Home
Financial information regarding the Company's reportable segments
Net Sales		1,461,894	1,456,208	1,320,988
Adjusted EBITDA		166,465	154,689	129,299
Depreciation and amortization		(93,027)	(96,611)	(95,880)
Capital Expenditures:		86,048	100,531	93,980
Total Assets		1,625,596	1,615,917	1,610,058
Operating Segments | Food + Beverage
Financial information regarding the Company's reportable segments
Net Sales		523,643	511,112	407,435
Adjusted EBITDA		71,531	79,377	71,995
Depreciation and amortization		(40,337)	(40,323)	(37,768)
Capital Expenditures:		32,378	34,136	29,956
Total Assets		552,871	574,269	549,270
Intersegment
Financial information regarding the Company's reportable segments
Net Sales		(35,737)	(38,095)	(33,190)
Intersegment | Pharma
Financial information regarding the Company's reportable segments
Net Sales		(11,193)	(13,372)	(8,328)
Intersegment | Beauty + Home
Financial information regarding the Company's reportable segments
Net Sales		(23,360)	(22,186)	(22,837)
Intersegment | Food + Beverage
Financial information regarding the Company's reportable segments
Net Sales		(1,184)	(2,537)	(2,025)
Corporate & Other
Financial information regarding the Company's reportable segments
Adjusted EBITDA		(62,930)	(52,314)	(43,443)
Restructuring initiatives		0	(12,313)	95
Depreciation and amortization		(5,946)	(7,409)	(10,778)
Capital Expenditures:		29,491	29,686	15,690
Transfer of Corporate Technology Expenditures		(1,886)	(10,495)	(11,507)
Total Assets		$ 152,148	$ 117,666	$ 280,944